Valence-Logo
Beliebt
Anmelden
Loading data for CI — first visit, this takes a few seconds.

Zur Watchlist hinzufügen

Cigna Group

NYSE: CI · Echtzeitkurs · USD
278.50
+3.17 (1.15%)
Zum Schluss: Aug 18, 2026, 3:59 PM
282.00
+1.26%
Vorbörslich: 6:47 AM

Cigna Group (CI) Stock Price, Analysis & Data

1.15%
Geldn/a
Marktkapitalisierung73.59 Mrd
Umsatz (TTM)282.38 Mrd
Nettogewinn (TTM)6.42 Mrd
Beta0.32
EPS (ttm)24.17
KGV (TTM)11.39
Forward-KGV8.32
KBV (TTM)1.72
KUV (TTM)0.26
Earnings DateNov 5, 2026
Briefn/a
Volumen858,435
Ø Vol. (20D)1,693,834
Eröffnung278.50
Vortagesschluss275.33
Tagesspanne277.73 - 282.58
52-Wk Range239.51 - 315.47
Analystn/a
Kurszieln/a
Dividenden$6.24 (2.24%)
Ex-Dividenden-Datum8. Sept. 2026

Über CI

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug u...

[Mehr lesen]
Branche Healthcare Plans
Sektor Healthcare
IPO Datum Mar 31, 1982
Mitarbeiter 65,669
Börse NYSE
Tickersymbol CI
Website https://www.thecignagroup.com
Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von Cigna 273.85 Mrd, ein Anstieg von 11.26% im Vergleich zum Vorjahr (246.15 Mrd). Der Gewinn lag bei 5.96 Mrd, ein Anstieg von 73.47 %.

Finanzberichte

Gewinnüberraschung

Cigna hat die Quartalszahlen am Jul 30, 2026 veröffentlicht:
  • Umsatz von $71.4 Mrd verfehlt die Erwartungen um $0, mit 6.65% Wachstum im Jahresvergleich.
  • EPS von 7.78 übertrifft die Erwartungen um 0.18, mit 8.06% Wachstum im Jahresvergleich.

    • Nächste Ergebnisveröffentlichung

    Cigna Group wird voraussichtlich die Quartalszahlen veröffentlichen am Nov 5, 2026, vor Börseneröffnung.
    Analysten erwarten einen Umsatz von ... Upgrade
    news image

    vor 1 Tag · Zacks

    Is CVS Stock a Buy as Earnings Improve but Key Risks Remain Elevated?

    CVS Health enters the second half of 2026 with stronger earnings and Aetna gains, but medical costs and Caremark risks cloud the recovery.

    news image

    vor 1 Tag · Zacks

    CVS' Q2 EPS Gains From Improved Health Care Benefits Profitability

    CVS Health's Q2 EPS jumps more than 40% as Health Care Benefits profitability improves, prompting a major boost to its 2026 AOI outlook.

    news image

    vor 1 Tag · StockStory

    Q2 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks

    Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q2 health insurance providers earnings season.

    news image

    vor 4 Tagen · Zacks

    Can CVS Sustain Its 2026 Recovery After Raising Earnings Guidance?

    CVS Health is rebuilding momentum as Aetna drives stronger profits and higher 2026 guidance, but medical costs and PBM changes could test the recovery.

    news image

    vor 5 Tagen · Trefis

    The Signs Before UnitedHealth Stock Ran Were In Its Own Exit Plan

    Management had named the plan exits, the Medicare margin target and the repricing date before the run began.

    Seite 1 von 2